A detailed history of Black Rock Inc. transactions in Sol Gel Technologies Ltd. stock. As of the latest transaction made, Black Rock Inc. holds 3,089 shares of SLGL stock, worth $1,668. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,089
Previous 3,089 -0.0%
Holding current value
$1,668
Previous $3,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 09, 2021

SELL
$8.85 - $12.5 $3,584 - $5,062
-405 Reduced 11.59%
3,089 $31,000
Q2 2021

Aug 11, 2021

BUY
$9.53 - $14.7 $33,297 - $51,361
3,494 New
3,494 $43,000

Others Institutions Holding SLGL

About Sol-Gel Technologies Ltd.


  • Ticker SLGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,129,500
  • Market Cap $12.5M
  • Description
  • Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has compl...
More about SLGL
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.